(Q47827760)

English

What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms.

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms. (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

author name string

Richard G Stock

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

Nelson N Stone

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

Mehud Dahlal

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

Yeh Chi Lo

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

83-89

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute urinary morbidity following I-125 interstitial implantation of the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal resolution of urinary morbidity following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical significance of a positive post-irradiation prostatic biopsy without metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1538-4721%2802%2900017-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1538-4721(02)00017-X

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15062175

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47827760&oldid=1418453452"